<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>LA031489-0054</title>
	</head>
	<body>
		<main>
			<p><P> March 14, 1989, Tuesday, Valley Edition  </P> <P> VALLEY ROUNDUP: SEREX, PLASMA-PROCESSING FIRM, PLANS SALE OF STOCK  </P> <P> Serex International, a Van Nuys company that acquires and resells human blood  plasma, plans to go public by selling 500,000 common shares of stock.  </P> <P> In a filing with the Securities and Exchange Commission, Serex proposed selling  the stock for $5 a share, or a total of $2.5 million. Excluding underwriting  commissions and other costs, the offering would raise $2.13 million for Serex.  </P> <P> Serex acquires and processes blood from people who had infections or diseases  that produce "rare and special" antibodies. Serex's customers further treat the  antibodies to create therapeutic products for other patients.  </P> <P> Serex said it earned $158,835 on sales of $1.29 million in its fiscal year that  ended May 31.  </P></p>
		</main>
</body></html>
            